Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CNTA stock hub

Centessa Pharmaceuticals plc has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CNTAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CNTA

In the news

Latest news · CNTA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-57.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-28.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CNTA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001847903
Company name	Centessa Pharmaceuticals plc
Country	United Kingdom
Country code	US
Cusip	152309100
Employees	118
Employees Change	41%
Employees Change Percent	53.25
Enterprise value	$6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-05-28
Isin	US1523091007
Last refreshed	2026-05-10
Market cap	$6.1B
Market cap category	Mid-Cap
Price	$39.6
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CNTA
Website	https://centessa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.09%
FCF yield	-3.41%
P/B ratio	12.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-250.6M
Net Income Growth Years	1%
Profit Per Employee	$-2.1M
ROA	-27.43
Roa5y	-25.12
ROCE	-42.41
ROE	-57.38
Roe5y	-75.18
ROIC	-28.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	227.23%
Cagr3y	103.59%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$641.8M
Cash	$276.6M
Current Assets	$348.7M
Current Liabilities	$36.6M
Debt	$117.8M
Debt Equity	$0.24
Equity	$487.3M
Interest Coverage	-22.69
Liabilities	$154.4M
Long Term Assets	$293.1M
Long Term Liabilities	$117.8M
Net Cash	$158.8M
Net Cash By Market Cap	$2.59
Net Cash Growth	-4.64%
Net Debt Equity	$-0.33
Tangible Book Value	$487.3M
Tangible Book Value Per Share	$3.15
WACC	10.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.53
Net Working Capital	$35.5M
Quick ratio	9.11
Working Capital	$312.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.73%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	226.96%
200-day SMA	25.75
3Y total return	744.24%
50-day SMA	34.23
50-day SMA vs 200-day SMA	50over200
All Time High	40.26
All Time High Change	-1.65%
All Time High Date	2026-03-31
All Time Low	2.89
All Time Low Change	1,272.44%
All Time Low Date	2022-06-03
ATR	0.5
Beta	1.14
Beta1y	1.09
Beta2y	1.2
Ch YTD	58.32
High	39.75
High52	40.26
High52 Date	2026-03-31
High52ch	-1.65%
Low	39.53
Low52	10.95
Low52 Date	2025-06-05
Low52ch	261.6%
Ma50ch	15.69%
Premarket Change Percent	0.13
Premarket Price	$39.66
Premarket Volume	17,729
Price vs 200-day SMA	53.74%
RSI	72.33
RSI Monthly	78.93
RSI Weekly	77.7
Sharpe ratio	1.99x
Sortino ratio	4.91
Total Return	-14.73%
Tr YTD	58.32
Tr1m	0.11%
Tr1w	0.06%
Tr3m	68.56%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	7
Analyst Price Target Top	$38.75
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.4
Earnings Revenue Estimate	382,180x
Earnings Revenue Estimate Growth	-97.45x
Operating Income	$-256.7M
Price target	$43.17
Price Target Change	$9.03
Price Target Change Top	$-2.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,983,692%
Float Percent	63.33%
Shares Insiders	0.64%
Shares Institutions	55.72%
Shares Out	154,728,966
Shares Qo Q	8.15%
Shares Yo Y	14.73%
Short Ratio	0.73
Short Shares	2.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-242.8M
Average Volume	2,134,171.4x
Bv Per Share	3.15
CAPEX	$-371,000
Ch1m	0.11
Ch1w	0.06
Ch1y	227
Ch3m	68.56
Ch3y	744.2
Ch6m	79
Change	-0.04%
Change From Open	-0.16
Close	39.61
Days Gap	0.13
Depreciation Amortization	343,000
Dollar Volume	27,013,926.3
Earnings Date	2026-08-04
Earnings Time	bmo
EBIT	$-256.7M
EBITDA	$-256.3M
EPS	$-1.78
F Score	1
FCF	$-209.2M
FCF EV Yield	-3.51x
FCF Per Share	$-1.35
Financing CF	318,909,000
Fiscal Year End	December
Founded	2,020
Income Tax	$1.3M
Investing CF	-153,436,000
Ipr	97.98
Iprfo	95.53
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-31
Ma150	28.03
Ma150ch	41.27%
Ma20	39.55
Ma20ch	0.12%
Net CF	-42,071,000
Next Earnings Date	2026-05-22
Open	39.66
Optionable	Yes
Position In Range	29.55
Post Close	39.6
Postmarket Change Percent	-0.01
Postmarket Price	$39.59
Ppne	10,516,000
Pre Close	39.61
Price Date	2026-05-08
Ptbv Ratio	12.57
Relative Volume	0.32x
Share Based Comp	33,644,000
Tr6m	79%
Volume	682,256

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CNTA pay a dividend?

Capital-return profile for this ticker.

Performance

CNTA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CNTA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+55.7%

Float: +63.3% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CNTA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.3

Above 70: short-term overbought

Price vs 200-day MA

+53.7%

50/200-day relationship not available

Beta (5Y)

1.14

Moves roughly with the market

Sharpe ratio

1.99

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CNTA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CNTA stock rating?

Centessa Pharmaceuticals plc is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CNTA analysis?

The full report lives at /stocks/CNTA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CNTA?

The latest report frames CNTA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CNTA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.